[go: up one dir, main page]

WO2011048388A3 - Oral pharmaceutical and nutraceutical compositions - Google Patents

Oral pharmaceutical and nutraceutical compositions Download PDF

Info

Publication number
WO2011048388A3
WO2011048388A3 PCT/GB2010/001968 GB2010001968W WO2011048388A3 WO 2011048388 A3 WO2011048388 A3 WO 2011048388A3 GB 2010001968 W GB2010001968 W GB 2010001968W WO 2011048388 A3 WO2011048388 A3 WO 2011048388A3
Authority
WO
WIPO (PCT)
Prior art keywords
oral pharmaceutical
nutraceutical compositions
nutraceutical
pharmaceutical
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2010/001968
Other languages
French (fr)
Other versions
WO2011048388A2 (en
Inventor
Ingvild Johanne Haug
Kurt Ingvar Draget
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROBIO ASA
Original Assignee
PROBIO ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROBIO ASA filed Critical PROBIO ASA
Publication of WO2011048388A2 publication Critical patent/WO2011048388A2/en
Publication of WO2011048388A3 publication Critical patent/WO2011048388A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides an oral pharmaceutical or nutraceutical composition comprising a pharmaceutical or nutraceutical agent disposed within a gelatin matrix, wherein said gelatin matrix further contains carrageenan at a content such that a 5mm thick sheet of said matrix would not dissolve within 4 hours at 37°C in an aqueous 0.1M HC1 solution containing 0.034 M NaC1.
PCT/GB2010/001968 2009-10-22 2010-10-22 Oral pharmaceutical and nutraceutical compositions Ceased WO2011048388A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0918590.1 2009-10-22
GB0918590A GB0918590D0 (en) 2009-10-22 2009-10-22 Composition

Publications (2)

Publication Number Publication Date
WO2011048388A2 WO2011048388A2 (en) 2011-04-28
WO2011048388A3 true WO2011048388A3 (en) 2011-06-30

Family

ID=41426585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2010/001968 Ceased WO2011048388A2 (en) 2009-10-22 2010-10-22 Oral pharmaceutical and nutraceutical compositions

Country Status (2)

Country Link
GB (1) GB0918590D0 (en)
WO (1) WO2011048388A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5878669B1 (en) * 2015-08-19 2016-03-08 三生医薬株式会社 Enteric capsule
CA3049828A1 (en) 2017-01-24 2018-08-02 Societe Des Produits Nestle S.A. Compositions comprising anti-fel d1 antibodies and methods for reducing at least one symptom of human allergy to cats
CA3057078A1 (en) * 2017-03-20 2018-09-27 Bayer Healthcare Llc Chewable gel products for active pharmaceutical ingredients
CN116807978A (en) * 2022-12-09 2023-09-29 技源健康科技(江苏)有限公司 A self-heating gel particle preparation that assists in swallowing medication and its preparation method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033924A1 (en) * 1997-12-26 1999-07-08 Warner-Lambert Company Gelatine compositions
EP1184033A1 (en) * 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
WO2004012701A2 (en) * 2002-08-02 2004-02-12 Scitech Centre NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.
WO2007085840A1 (en) * 2006-01-25 2007-08-02 Probio Nutraceuticals As Emulsion
WO2009095670A1 (en) * 2008-01-29 2009-08-06 Ayanda As Soft gel capsules

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033924A1 (en) * 1997-12-26 1999-07-08 Warner-Lambert Company Gelatine compositions
EP1184033A1 (en) * 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
WO2004012701A2 (en) * 2002-08-02 2004-02-12 Scitech Centre NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.
WO2007085840A1 (en) * 2006-01-25 2007-08-02 Probio Nutraceuticals As Emulsion
WO2009095670A1 (en) * 2008-01-29 2009-08-06 Ayanda As Soft gel capsules

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAUG I J ET AL: "Physical behaviour of fish gelatin-kappa-carrageenan mixtures", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS, LTD. BARKING, GB, vol. 56, no. 1, 17 May 2004 (2004-05-17), pages 11 - 19, XP004504327, ISSN: 0144-8617, DOI: DOI:10.1016/J.CARBPOL.2003.10.014 *
PRANOTO ET AL: "Characterizations of fish gelatin films added with gellan and kappa-carrageenan", LEBENSMITTEL WISSENSCHAFT UND TECHNOLOGIE, ACADEMIC PRESS, LONDON, GB, vol. 40, no. 5, 22 February 2007 (2007-02-22), pages 766 - 774, XP005931403, ISSN: 0023-6438, DOI: DOI:10.1016/J.LWT.2006.04.005 *

Also Published As

Publication number Publication date
GB0918590D0 (en) 2009-12-09
WO2011048388A2 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
WO2011067667A3 (en) Fexofenadine microcapsules and compositions containing them
PL2328618T3 (en) Pharmaceutical composition of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4- oxoquinoline-3-carboxamide and administration thereof
IL250937A0 (en) Pharmaceutical compositions and kits containing an acid sphingomyelinase
IL192925A0 (en) 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
AP2416A (en) Stabilized pharmaceutical compositions comprising fesoterodine.
EP2172225A8 (en) Seamless capsule
PL2068822T3 (en) Self preserved aqueous pharmaceutical compositions
IL199835A (en) Acid activated antimicrobial peptides, pharmaceutical compositions comprising the same and use thereof for the preparation of medicaments
IL203915A (en) 2-benzylphenyl-6-hydroxymethyl-tetrahydro-2h-pyran-3,4,5-triol derivatives and pharmaceutical compositions comprising the same
BRPI0909030A2 (en) modified release pharmaceutical compositions comprising mycophenolate and processes therefor.
BR112012000530A8 (en) use of a population of metallic nanoparticles, and, pharmaceutical composition.
IL206808A (en) Indolyl-pyridone derivatives, pharmaceutical compositions comprising the same and uses thereof
BRPI0809661A2 (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING PREGABALINE
BRPI1009823A2 (en) "composition comprising a drug dispensing system, a first and a second composition set, and a kit."
EP2474522A4 (en) AGOMÉLATINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
WO2010122332A3 (en) Xanthan gum and swellable particulate containing composition and uses thereof
IL202235A (en) 2-phenylethylaminoacetic acid amides and thioamides, derivatives thereof and pharmaceutical compositions comprising the same
WO2011128627A3 (en) Oral veterinary pharmaceutical and nutraceutical compositions
IL180036A0 (en) Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
WO2011048388A3 (en) Oral pharmaceutical and nutraceutical compositions
SI1886686T1 (en) Pharmaceutical composition containing mometasone furoate
IL213408A (en) Conjugates comprising nanoparticles coated with platinum containing compounds, processes for their preparation, pharmaceutical compositions comprising them and uses thereof
BRPI0700133A (en) pharmaceutical composition comprising tramadol and ketoprofen in combination
EP2007371A4 (en) Lactate and calcium containing pharmaceutical composition and uses thereof
IL211395A0 (en) Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3 diol and paracetamol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10771805

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10771805

Country of ref document: EP

Kind code of ref document: A2